Dr. Chenming Hu, Professor Emeritus of EECS at UC Berkeley, is the visionary inventor of the FinFET or 3D transistor architecture. He is a world’s foremost authority on CMOS device physics, modeling and manufacturing. To address the limits of Moore’s law scaling in CMOS transistors, Dr. Hu conceived the tri-gate FinFET design that enables further scaling and integration in the third dimension by stacking-up transistors vertically. Intel began commercializing the 3D transistor based chips in 2011, with most others following soon. Dr. Hu served as Chief Technology Officer of TSMC from 2001 to 2004. He has authored four books and 900 research papers, and has been granted over 100 US patents.
GENOME SEQUENCING
Sequencing a person’s genome can identify susceptibility to various diseases, aid in early disease diagnosis, and enable precision medicine – personalization of therapy based on individual specific genomic biomarkers.
CANCER DIAGNOSTICS
Detecting diseases in early stages dramatically improves therapeutic outcomes. In Cancer, average 5 year survival rate is close to 90% when diagnosed at stage 1, and stands at less than 25% when diagnosed at stage 4. In contrast, cost of therapy when diagnosed post metastasis is approximately 2.5 times that when diagnosed at early stages.
